Articles, App Notes, Case Studies, & White Papers

  1. Meet Regulation Requirements With RTU Vials And Cartridges 10/9/2025

    Sterile manufacturing remains vital, with resilient supply chains preventing shortages. Industry and regulators prioritize integrity as demand surges, making it the fastest-growing pharmaceutical segment.

  2. Leveraging Integration At Each Phase Of A Drug Delivery System Project 4/8/2021

    By forging deeper partnerships with customers, the full depth and breadth of our knowledge, experience and competencies can bring benefits at multiple levels. See how an integrated offering helps at each phase of a drug delivery system project.

  3. Lyophilization: Protecting And Preserving Biologics 2/4/2026

    Discover how lyophilization revolutionizes biologic drug manufacturing and ensures potent, stable treatments for complex diseases.

  4. What's Standing In The Way Of Mainstream NAMs Adoption? 5/19/2026

    NAM adoption is constrained by inconsistent cell sourcing, limited standardization, and regulatory uncertainty — barriers that must be addressed to enable reproducible evidence and regulatory trust.

  5. What Capacity And Cost Won't Tell You About A Fill-Finish CDMO 8/3/2026

    Evaluating fill-finish CDMOs beyond cost and capacity ensures long-term success. Strategic focus on technical depth, scalability, and modern compliance reduces risk.

  6. Cartridge Filling: Where Precision, Process Control, And Experience Matter 9/1/2026

    Cartridge drug delivery demands strict controls to guarantee dose accuracy. Early development and testing eliminate variability, prevent defects, and protect patient safety.

  7. Enriching Sterile Fill/Finish Services With A Patient-Centric Approach 12/18/2025

    Through early collaboration and advanced aseptic technology, organizations can overcome complex formulation challenges to ensure safe, effective treatments reach patients more efficiently than before.

  8. Why Early Device Decisions Matter: How Immunovant Accelerated Its Program 10/15/2026

    Deferring autoinjector selection can seem to preserve flexibility, yet it often moves constraints downstream. Integrating the device during Phase IIb changed one program's timeline and removed bridging work.

  9. Fixtures And Surrogates For Combination Product Performance Testing 5/16/2025

    The combination product market is consistently expanding. Transitioning from traditional vial systems to needle-based combination products presents several challenges that require careful consideration.

  10. An Elegant Solution For Delivery Of Acid Sensitive Pharmaceuticals 12/6/2022

    Sustained release drug delivery products offer effective therapies in the treatment of serious chronic diseases, and their development requires customized solutions with tunable material properties.